IRVINE, Calif., June 13 /PRNewswire-FirstCall/ -- CalbaTech, Inc. (OTC Bulletin Board: CLBE - News), an emerging life sciences company (http://www.CalbaTech.com ) concentrating on banking adult stem cells for possible future therapeutic uses and providing products and platforms to the biotech, pharmaceutical research market and to academic institutions, today in a letter to all shareholders said that a comparison of sixteen companies in the stem cell arena showed CalbaTech third in EBITDA (Earnings Before Income Taxes, Depreciation and Amortization) and first in average daily trading volume.
